Exact Mass: 502.2115

Exact Mass Matches: 502.2115

Found 331 metabolites which its exact mass value is equals to given mass value 502.2115, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Verrucarin A

Muconomycin A

C27H34O9 (502.2203)

A trichothecene antibiotic which incorporates a triester macrocyclic structure and an exocyclic methylene epoxide group. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D000970 - Antineoplastic Agents

Cyclocalamin

Methyl 2-[7-(furan-3-yl)-18-hydroxy-1,8,12,15,15-pentamethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-13-yl]acetic acid

C27H34O9 (502.2203)

Cyclocalamin is found in citrus. Cyclocalamin is a constituent of calamondin seeds (Citrus reticulata var. austera x Fortunella sp.)

Isocyclocalamin

Methyl 2-[7-(furan-3-yl)-17-hydroxy-1,8,12,15,15-pentamethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-13-yl]acetic acid

C27H34O9 (502.2203)

Isocyclocalamin is found in citrus. Isocyclocalamin is a constituent of a Citrus reticulata/Fortunella hybrid. Constituent of a Citrus reticulata/Fortunella hybrid. Isocyclocalamin is found in citrus.

Elastase Inhibitor III

methyl 3-({1-[(1-{2-[(1-chloro-4-methyl-2-oxopentan-3-yl)carbamoyl]pyrrolidin-1-yl}-1-oxopropan-2-yl)carbamoyl]ethyl}carbamoyl)propanoate

C22H35ClN4O7 (502.2194)

[3aR-[3aR,4R[E(E)],6E,9R,10Z,11aR]]-2-[[[9-(Acetyloxy)-2,3,3a,4,5,8,9,11a-octahydro-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl]oxy]carbonyl]-2-butenyl ester 2-(hydroxymethyl)-2-butenoic acid

[3aR-[3aR*,4R*[E(E)],6E,9R*,10Z,11aR*]]-2-[[[9-(Acetyloxy)-2,3,3a,4,5,8,9,11a-octahydro-6,10-dimethyl-3-methylene-2-oxocyclodeca[b]furan-4-yl]oxy]carbonyl]-2-butenyl ester 2-(hydroxymethyl)-2-butenoic acid

C27H34O9 (502.2203)

Maculalactone E

(+)-Maculalactone E

C34H30O4 (502.2144)

Khayalactone

(+)-Khayalactone

C27H34O9 (502.2203)

C27H34O9 (502.2203)

(aS,5S,6S,7S)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-5-[isobutyryl]oxybenzodioxolo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol|schisanwilsonin E

C27H34O9 (502.2203)

6-Deoxy-9|A-hydroxycedrodorin

C27H34O9 (502.2203)

methyl 2-[7-(furan-3-yl)-17-hydroxy-1,8,12,15,15-pentamethyl-5,18-dioxo-3,6,14-trioxapentacyclo[9.7.0.0^{2,4}.0^{2,8}.0^{12,16}]octadecan-13-yl]acetate

C27H34O9 (502.2203)

Cyclocalamin

methyl 2-[7-(furan-3-yl)-18-hydroxy-1,8,12,15,15-pentamethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0^{2,4}.0^{2,8}.0^{12,16}]octadecan-13-yl]acetate

nocamycin I(1-)

C26H32NO9 (502.2077)

An organic anion resulting from the deprotonation of the enol moiety of nocamycin I. The major species at pH 7.3.

LPI 11:0

C20H39O12P (502.2179)

ST 21:5;O3;GlcA

C27H34O9 (502.2203)

ST 21:6;O4;Hex

C27H34O9 (502.2203)

ST 27:7;O4;S

C27H34O7S (502.2025)

CCG258747

C28H27FN4O4 (502.2016)

CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1]. CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1].

(3s,4r,7r,9s,10s,12s,13s,15s,16r,17r,20s)-18-[(3r,4r)-3,4-dimethyl-5-oxooxolan-2-yl]-9,17-dihydroxy-4,17-dimethyl-19,21,22-trioxaheptacyclo[11.6.1.1¹,¹⁵.1⁷,¹⁰.0³,¹².0⁴,⁹.0¹⁶,²⁰]docosane-5,8-dione

(3s,4r,7r,9s,10s,12s,13s,15s,16r,17r,20s)-18-[(3r,4r)-3,4-dimethyl-5-oxooxolan-2-yl]-9,17-dihydroxy-4,17-dimethyl-19,21,22-trioxaheptacyclo[11.6.1.1¹,¹⁵.1⁷,¹⁰.0³,¹².0⁴,⁹.0¹⁶,²⁰]docosane-5,8-dione

C27H34O9 (502.2203)

3β-angeloyloxy-8-oxoeremophila-6,9-dien-12-oicacid ethyl ester

C27H34O9 (502.2203)

methyl (2r)-2-[(1s,2r,5s,6s,10s,11s,13s,14r,16s)-6-(furan-3-yl)-10-hydroxy-1,5,15,15-tetramethyl-8,17-dioxo-7,18-dioxapentacyclo[11.3.1.1¹¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-16-yl]-2-hydroxyacetate

methyl (1s,2r,4s,16r,17r,20s)-20-hydroxy-13-methoxy-4,7,17,22,22-pentamethyl-11-oxo-5,10,21,23-tetraoxahexacyclo[18.2.1.0¹,¹⁷.0⁴,¹⁶.0⁶,¹⁴.0⁸,¹²]tricosa-6,8(12),13-triene-2-carboxylate

methyl (2s)-2-[(1s,2r,5s,6s,10s,11s,13s,14r,16r)-6-(furan-3-yl)-10-hydroxy-5,14,15,15-tetramethyl-8,17-dioxo-7,18-dioxapentacyclo[11.3.1.1¹¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-16-yl]-2-hydroxyacetate

C27H34O9 (502.2203)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[4-(2-methylbut-3-en-2-yl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy]oxane-3,4,5-triol

C23H34O12 (502.205)

(1'r,2s,3'r,8'r,12's,13'r,18'z,20'z,24'r,25's)-12'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',17',22'-trione

(8r,9r,10s)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-8-yl 2-methylpropanoate

C27H34O9 (502.2203)

methyl 20-hydroxy-13-methoxy-4,7,17,22,22-pentamethyl-11-oxo-5,10,21,23-tetraoxahexacyclo[18.2.1.0¹,¹⁷.0⁴,¹⁶.0⁶,¹⁴.0⁸,¹²]tricosa-6,8(12),13-triene-2-carboxylate

C27H34O9 (502.2203)

methyl 2-[(1s,2s,3s,4r,7s,8s,12r,14r,15s,16r,17s,18s)-8-(furan-3-yl)-1,3,15-trihydroxy-7,16,18-trimethyl-10-oxo-9,13-dioxahexacyclo[14.2.1.0²,¹⁴.0³,¹².0⁴,¹⁸.0⁷,¹²]nonadecan-17-yl]acetate

methyl 2-[(1s,2s,3s,4r,7s,8s,12r,14r,15s,16r,17s,18s)-8-(furan-3-yl)-1,3,15-trihydroxy-7,16,18-trimethyl-10-oxo-9,13-dioxahexacyclo[14.2.1.0²,¹⁴.0³,¹².0⁴,¹⁸.0⁷,¹²]nonadecan-17-yl]acetate

(2e)-3-{[(3ar,4r,9s,11ar)-9-hydroxy-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl]oxy}-2-ethylidene-3-oxopropyl (2e)-2-[(acetyloxy)methyl]but-2-enoate

C27H34O9 (502.2203)

methyl 2-[(1r,2r,3r,7s,8s,11s,12r,13s,15s,17r)-7-(furan-3-yl)-3,17-dihydroxy-8,12,14,14-tetramethyl-5,18-dioxo-6,16-dioxapentacyclo[10.4.2.0²,¹¹.0³,⁸.0¹⁵,¹⁷]octadecan-13-yl]acetate

C27H34O9 (502.2203)

(1s,2r,4s,10r,11s,13r,15s,16r,17s,20s)-4-chloro-15-[(2r)-3,4-dimethyl-5-oxo-2h-furan-2-yl]-13,17-dihydroxy-10,16,20-trimethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁷,²⁰]icosa-5,7-dien-9-one

(1s,2r,4s,10r,11s,13r,15s,16r,17s,20s)-4-chloro-15-[(2r)-3,4-dimethyl-5-oxo-2h-furan-2-yl]-13,17-dihydroxy-10,16,20-trimethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁷,²⁰]icosa-5,7-dien-9-one

C28H35ClO6 (502.2122)

methyl 2-[(1r,3r,7s,8s,9s,12r,13s)-13-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]-6,6,8,12-tetramethyl-17-methylidene-5,15-dioxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C27H34O9 (502.2203)

2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C23H34O12 (502.205)